ישראל - עברית - Ministry of Health

dexcel ltd, israel - doxazosin as mesylate - טבליה - doxazosin as mesylate 1 mg - doxazosin - doxazosin - antihypertensive agent. for the treatment of benign prostatic hyperthropy.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - doxazosin as mesylate - קפליות - doxazosin as mesylate 2 mg - doxazosin - doxazosin - antihypertensive agent. for the treatment of benign prostatic hyperthropy.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - doxazosin as mesylate - קפליות - doxazosin as mesylate 4 mg - doxazosin - doxazosin - antihypertensive agent. for the treatment of benign prostatic hyperthropy.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - terazosin as hydrochloride dihydrate - טבליה - terazosin as hydrochloride dihydrate 5 mg - terazosin - terazosin - for symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (bph). for mild to moderate hypertension.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - terazosin as hydrochloride dihydrate - טבליה - terazosin as hydrochloride dihydrate 2 mg - terazosin - terazosin - for symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (bph). for mild to moderate hypertension.

ישראל - עברית - Ministry of Health

biotis ltd - terazosin as monohydrachloride dihydrate - טבליה - terazosin as monohydrachloride dihydrate 5 mg - terazosin - terazosin - for symptomatic treatment of urinary obstruction caused by benign prostatic hypertrophy (bph). for mild to moderate hypertension.

ישראל - עברית - Ministry of Health

biotis ltd - terazosin as monohydrachloride dihydrate - טבליה - terazosin as monohydrachloride dihydrate 10 mg - terazosin - terazosin - for symptomatic treatment of urinary obstruction caused by benign prostatic hypertrophy (bph). for mild to moderate hypertension.

ישראל - עברית - Ministry of Health

teva israel ltd - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

ישראל - עברית - Ministry of Health

abic ltd. - omeprazole - קפסולות - omeprazole 20 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. reflux esophagitis:- treatment ; - long-term management; - maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. treatment of severe reflux oesophagitis in children from one year of age and older. - maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer. - zollinger-ellison syndrome. - treatment and prevention of nsaid - associated duodenal and gastric ulcers or erosions in high risk patients.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - omeprazole - קפליות - omeprazole 20 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.